A new long-acting HIV treatment could expand options for people who have trouble taking daily pills and whose virus is ...
A new long-acting HIV treatment could expand options for people who have trouble taking daily pills and whose virus is ...
Small HIV trials suggest combinations of immune therapies may help some people control the virus without daily medication, although larger studies and sustained funding are still needed.
Are we unraveling years of progress on fighting HIV/AIDS? For the past two decades, the US has led the global response to a virus and disease that have together claimed more than 40 million lives. But ...
Promising new drugs to prevent and treat HIV have the potential to transform the response to the disease. But getting these drugs to those who need it most will be critical, says Beatriz Grinsztejn, ...
Nearly half a century has passed since the first recognized case of AIDS in the U.K. in December 1981. During that time, ...
People living with HIV need to take antiretroviral treatment for life to prevent the virus from multiplying in their body. But some people, known as 'post-treatment controllers,' have been able to ...
At the Aids 2026 conference, Brazilian advocates said health systems need to be more independent from foreign funding HIV advocates from Brazil, whose health system operates independently from foreign ...
By Divina Suson and Nef Luczon ILIGAN CITY – Health officials in Lanao del Sur and Northern Mindanao urged the public to get ...
• For HIV PrEP, options include daily or episodic emtricitabine/tenofovir disoproxil fumarate (Truvada) or daily emtricitabine/tenofovir alafenamide (Descovy) and injectable cabotegravir (Apretude) ...
“You are enough, just as you are … I have to remind myself of that on a daily basis. It’s not easy” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results